Concepedia

E Peeva

EP

Statistics

Publications

3

Citations

130

H-Index

3

Active since

2015

Affiliations

Pfizer (United States)(Current)

E Peeva is an author at Pfizer (United States) specializing in medicine, digestive system diseases, and clinical trials.

Top concepts

Publications per year

2015–2021

3

Publications

3

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study

G Schmieder, Zoé Kececioglu Draelos, David M. Pariser et al. · British Journal of Dermatology · 2017 · 87 citations

Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus

Katherine Masek-Hammerman, E Peeva, Alaa Ahmad et al. · Clinical & Experimental Immunology · 2015 · 29 citations · Full text

, , +18

OP33 Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study

William J. Sandborn, Silvio Danese, Jarosław Leszczyszyn et al. · Journal of Crohn s and Colitis · 2021 · 14 citations · Full text

, , +14

1–3 of 3